Skip to search.
 STI Down0.49%

Novo Nordisk A/S (NVO)

-NYSE

158.76 Down 3.11(1.92%) 04:03 SGT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2008Dec 31, 2007Dec 31, 2006
Total Revenue 8,632,294   8,261,623   6,857,511  
Cost of Revenue1,915,656  1,934,118  1,696,545  
Gross Profit 6,716,638   6,327,505   5,160,966  
Operating Expenses
Research Development1,427,125  1,424,568  1,117,932  
Selling General and Administrative2,944,830  2,938,603  2,424,900  
Non Recurring -  261,688  54,693  
Others -  (63,398) -  
Total Operating Expenses -  4,561,460   -  
Operating Income or Loss 2,344,684   1,766,045   1,563,441  
Income from Continuing Operations
Total Other Income/Expenses Net131,134  464,718  131,865  
Earnings Before Interest And Taxes2,452,320  2,230,763  1,695,306  
Interest Expense46,617  63,990  52,392  
Income Before Tax2,405,703  2,166,773  1,642,914  
Income Tax Expense577,975  483,678  480,024  
Minority Interest -   -   -  
Net Income From Continuing Ops1,827,728  1,683,095  1,116,870  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 1,827,728   1,683,095   1,116,870  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 1,827,728   1,683,095   1,116,870  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.